LSK BIOPHARMA
LSK BioPartners, Inc (dba LSK BioPharma) is a privately-held pharmaceutical company based in Salt Lake City, Utah with offices in South San Francisco (and Pangyo, South Korea). LSK BioPharma (LSKB) specializes in clinical development of promising therapies for unmet medical needs in cancer. LSKB is developing two proprietary drug candidates; rivoceranib (Apatinib), a VEGFR-2 inhibitor which has demonstrated clinical efficacy in a variety of solid tumors and a BTK/JAK3 inhibitor with the potential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent. LSKB holds worldwide rights for rivoceranib excluding China and has partnered for development and marketing in South Korea.
LSK BIOPHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2005-01-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.elevartherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(801) 303-7440
Total Funding:
20 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail ReCAPTCHA Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Founder
Official Site Inspections
http://www.elevartherapeutics.com Semrush global rank: 3.26 M Semrush visits lastest month: 5.06 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "LSK BioPharma"
Elevating Outcomes - Elevar Therapeutics
Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or …See details»
Mission and Values - Elevar Therapeutics
We are on a mission to elevate treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. Watch “Sarah and Greg’s Story: Hope Is Stronger Than Fear,” a short video about one family’s journey …See details»
Leadership - Elevar Therapeutics
With more than 30 years of experience as a financial and commercial executive, Wade Smith joined Elevar Therapeutics in January 2022 after spending the previous decade at Viatris (formerly Mylan Pharmaceuticals), a global health …See details»
Elevar Therapeutics - LinkedIn
Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or...See details»
Elevar Therapeutics - Crunchbase Company Profile
Elevar Therapeutics specializes in clinical development of promising therapies for unmet medical needs in cancer. View contacts for Elevar Therapeutics to access new leads and connect with decision-makers.See details»
Elevar Therapeutics Announces New Appointments to its Board of …
Oct 26, 2021 · Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients …See details»
Elevar Therapeutics Announces New Appointments to Strengthen …
Sep 27, 2021 · Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients …See details»
Careers - Elevar Therapeutics
We offer competitive compensation, a generous benefits and wellness package, along with opportunities for professional growth. Bonus—we also genuinely like each other! We work hard, we laugh, and together we are better. Elevate your …See details»
Elevar Therapeutics Announces CEO Transition and New Board …
Jul 20, 2021 · Elevar Therapeutics has offices in Utah, California and South Korea, and additional information is available at www.elevartherapeutics.com/. Founded in 1975 and based in Seoul, …See details»
Elevar Therapeutics Announces Appointment of Jenny Gizzi to …
SALT LAKE CITY, Jan. 5, 2022 /PRNewswire/ -- Elevar Therapeutics, Inc. ("Elevar"), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences …See details»
Elevar Therapeutics - Overview, News & Similar companies
Aug 21, 2022 · View Elevar Therapeutics (www.elevartherapeutics.com) location in Utah, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Investors - Elevar Therapeutics
Aug 10, 2023 · Discussion on Phase 3 Study of Rivoceranib in Combination with Camrelizumab in Unresectable Hepatocellular Carcinoma (uHCC) Leadership and credibility to ensure the …See details»
Elevar Therapeutics Submits New Drug Application to FDA for
May 17, 2023 · “Elevar Therapeutics’ submission of a New Drug Application for the combination of rivoceranib and camrelizumab marks an important milestone in our effort to provide an …See details»
Elevar Therapeutics Announces CEO Transition and New Board …
Jul 20, 2021 · Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients …See details»
Working at Elevar Therapeutics - Glassdoor
Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or …See details»
Elevar Therapeutics Announce New Data Highlighting Patient …
May 18, 2021 · Elevar Therapeutics (formerly LSK BioPharma) is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences …See details»
Press Releases - Elevar Therapeutics
SALT LAKE CITY, USA., July 20, 2021 — Elevar Therapeutics, Inc. (“Elevar”), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and …See details»
Elevar Therapeutics Announces New Appointments to Strengthen …
Jul 8, 2021 · Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have …See details»
Elevar Therapeutics Reports Landmark Median Overall Survival of …
FORT LEE, N.J., May 30, 2024 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd., today announced the landmark overall survival (OS) …See details»
Elevar Therapeutics Receives Orphan Drug Designation from FDA …
Nov 11, 2021 · Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients …See details»